hg_18125.1

Basic information about the TSS

---

TSS ID: hg_18125.1 Species: human Chr: chr1		Start: 235128935 End: 235128946 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK289810 Distance: 0 GeneID: 9804 HGNC/MGI_ID: HGNC:20947 UniProt_ID:

Gene_name: translocase of outer mitochondrial membrane 20 Gene_symbol: TOMM20 Gene_synonyms: KIAA0016 MAS20 MOM19 TOM20 Gene_source: HGNC:20947

TATA-Box annotation

---

Distance to TSS:	-104
Nearest PromoterID:	NM_014765
Entrez ID:	9804
Nearest Unigene:	Hs.533192
Nearest Refseq:	NM_014765
Nearest Ensembl:	ENSG00000173726
Gene Name:	translocase of outer mitochondrial membrane 20
Gene Alias:	MAS20|MOM19|TOM20
Gene Description:	translocase of outer mitochondrial membrane 20
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.651741
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TOMM20 p2@TOMM20 p3@TOMM20 p4@TOMM20 p5@TOMM20
Sample		p1@TOMM20	p2@TOMM20	p3@TOMM20	p4@TOMM20	p5@TOMM20
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	230.45	42.08	12.66	0.97	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	234.28	43.30	11.53	0.81	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	234.96	36.27	13.89	0.96	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	203.34	40.96	11.85	1.04	1.66
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	221.59	42.97	13.27	2.02	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	205.25	34.69	11.43	0.58	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	274.97	43.58	13.73	1.09	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	208.55	44.08	9.69	1.21	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	217.99	44.45	16.03	1.50	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	223.16	47.53	11.01	2.32	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	206.56	53.76	12.94	0.40	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	210.59	55.29	10.16	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	232.44	5.48	3.87	0.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	184.03	5.71	2.10	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	207.70	8.78	2.20	0.88	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	196.92	7.54	3.02	0.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	201.59	5.68	2.18	0.66	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	185.18	7.17	3.37	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	194.07	3.73	2.13	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	224.91	8.42	3.01	0.90	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	215.58	6.82	3.61	0.67	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	208.53	9.15	3.11	0.86	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	191.69	7.63	2.97	0.90	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	213.06	8.49	2.91	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	215.16	11.87	3.87	1.03	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	208.26	7.60	4.11	1.58	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	211.54	8.79	3.30	2.20	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	183.65	10.14	4.95	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	197.06	9.37	3.07	0.81	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	226.75	9.95	3.62	1.63	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	188.41	9.21	4.19	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	211.60	9.57	2.74	1.76	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	172.62	8.02	2.95	0.42	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	185.89	9.24	3.79	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	207.93	10.66	3.93	2.06	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	212.70	9.39	4.02	1.72	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	200.91	10.83	5.11	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	190.41	8.87	3.02	2.01	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	186.91	10.80	4.05	1.62	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	198.05	11.52	1.92	1.44	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	171.74	11.29	1.65	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	174.94	8.93	2.78	1.32	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	204.14	10.76	3.37	0.21	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	194.93	9.27	2.62	0.87	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	182.90	10.44	2.01	0.60	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	180.53	11.40	3.26	1.40	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	186.17	9.84	3.60	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	171.68	5.96	2.38	1.19	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	165.65	10.29	1.91	0.96	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	154.68	9.71	3.24	1.42	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	174.42	8.81	7.17	1.02	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	187.68	10.67	3.78	1.11	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	447.75	41.98	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	189.49	10.65	3.90	1.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	168.01	11.27	3.65	1.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	147.65	10.91	3.36	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	113.43	4.59	2.76	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	199.00	11.34	4.86	0.65	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	198.80	11.56	3.53	1.61	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	141.76	11.63	2.51	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	149.47	13.40	6.35	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	136.27	7.85	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	85.19	4.78	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	108.05	7.14	1.70	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	165.38	13.32	3.57	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	130.99	8.16	2.13	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	210.13	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	229.03	31.59	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	120.90	8.78	0.98	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	133.89	10.41	0.99	0.99	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	122.91	8.91	2.81	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	156.65	10.27	1.32	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	165.81	12.99	1.55	0.31	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	160.21	10.70	1.22	1.83	0.31
Adipocyte - breast, donor1	11376-118A8	109.13	11.88	2.22	1.27	0.16
Adipocyte - breast, donor2	11327-117E4	81.82	8.66	2.09	0.80	0.96
Adipocyte - omental, donor1	11473-119C6	105.22	11.70	2.16	0.76	1.02
Adipocyte - omental, donor2	11474-119C7	80.73	11.21	0.75	0.00	2.99
Adipocyte - omental, donor3	11475-119C8	96.12	8.04	1.34	0.33	1.67
Adipocyte - perirenal, donor1	11476-119C9	111.01	12.76	0.64	0.64	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	60.47	5.50	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	56.00	3.61	1.35	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	82.89	3.65	2.95	0.17	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	83.12	3.91	0.98	0.78	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	70.52	7.72	2.06	0.00	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	71.92	6.13	0.84	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	71.13	8.23	0.59	1.18	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	86.30	8.61	2.41	0.64	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	64.23	5.49	1.61	0.00	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	65.05	6.40	1.60	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	81.24	6.12	2.78	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	71.53	8.32	1.66	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	61.28	6.28	0.75	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	61.52	5.56	1.96	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	56.33	4.87	0.61	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	52.82	5.75	1.99	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	19.72	2.15	0.36	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	38.34	0.00	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	51.99	5.04	1.26	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	63.59	3.35	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	71.70	3.49	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	172.21	5.26	0.92	0.80	0.23
Anulus Pulposus Cell, donor2	11463-119B5	133.96	6.12	1.47	0.98	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	106.03	5.84	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	108.54	4.34	2.17	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	130.56	2.14	4.28	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	98.35	6.28	1.20	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	134.05	7.59	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	102.31	7.92	0.66	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	95.19	7.80	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	113.59	4.85	3.40	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	105.71	5.34	1.19	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	96.42	5.27	1.13	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	103.77	4.35	1.45	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	116.60	8.78	3.76	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	112.84	8.07	1.48	0.66	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	94.17	4.09	4.09	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	106.61	7.69	2.41	1.06	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	107.16	6.43	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	102.97	6.99	1.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	124.56	5.08	1.87	1.07	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	91.69	11.71	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	95.87	7.96	0.66	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	104.46	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	130.99	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	102.75	8.06	1.37	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	100.68	8.39	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	108.74	7.28	1.46	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	83.48	3.79	0.38	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	101.75	8.48	2.42	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	104.89	2.85	0.57	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	99.62	6.20	0.86	0.86	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	122.59	7.74	1.29	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	104.63	4.69	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	105.79	6.75	0.96	0.64	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	104.16	5.71	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	88.33	7.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	101.46	5.42	0.90	0.90	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	112.86	8.32	1.19	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	91.54	3.05	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	81.25	6.11	1.02	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	97.21	5.08	2.54	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	113.49	6.04	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	99.07	10.16	1.48	0.42	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	112.51	7.54	1.74	1.16	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	113.37	7.56	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	96.80	8.14	1.02	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	155.20	9.27	0.00	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	95.07	12.68	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	98.20	6.43	1.93	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	99.88	8.42	2.41	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	112.99	6.56	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	85.75	5.98	1.15	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	89.26	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	126.86	7.88	1.27	0.25	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	108.59	6.61	1.03	0.83	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	93.33	6.12	1.84	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	106.60	5.26	1.91	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	106.21	5.32	1.55	0.44	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	115.96	7.63	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	116.32	3.32	2.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	103.27	9.27	1.06	0.79	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	102.49	6.18	1.45	0.73	0.73
Astrocyte - cerebellum, donor1	11500-119F6	47.28	6.02	0.74	1.11	0.49
Astrocyte - cerebellum, donor2	11580-120F5	51.18	6.50	0.51	0.34	0.68
Astrocyte - cerebellum, donor3	11661-122F5	40.48	2.52	1.47	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	115.73	13.94	1.39	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	118.90	10.19	1.13	1.29	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	128.58	12.23	2.54	1.34	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	144.05	5.96	3.33	1.26	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	131.17	6.14	2.88	1.25	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	128.36	5.35	2.96	0.68	1.14
Basophils, donor1	12241-129G9	72.44	3.92	1.31	1.57	1.57
Basophils, donor2	12242-129H1	170.66	5.05	2.89	6.49	4.69
Basophils, donor3	12243-129H2	108.48	4.85	1.91	1.76	2.06
Bronchial Epithelial Cell, donor1	11511-119G8	59.08	3.23	1.08	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	32.00	1.37	0.00	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	258.25	7.17	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	57.74	4.39	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	56.77	4.57	1.46	0.62	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	76.69	3.22	0.69	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	152.05	6.12	2.88	1.26	1.26
Burkitt's lymphoma cell line:DAUDI	10422-106C8	212.19	8.04	2.89	1.13	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	385.22	13.97	6.99	4.19	3.26
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	268.93	11.83	3.52	7.99	5.76
CD133+ stem cells - cord blood derived, pool1	12223-129E9	279.23	31.03	10.34	20.68	20.68
CD14+ Monocytes, donor1	11224-116B9	102.57	3.38	3.38	3.38	1.13
CD14+ Monocytes, donor2	11305-117B9	98.18	7.80	2.04	2.78	1.30
CD14+ Monocytes, donor3	11381-118B4	99.45	6.15	2.20	3.73	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	133.03	3.40	0.85	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	126.99	2.65	2.27	1.14	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	131.50	4.60	0.99	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	93.23	3.47	0.58	0.29	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	74.53	3.62	1.21	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	72.02	3.32	1.42	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	75.16	1.00	1.67	0.33	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	64.31	3.59	1.10	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	65.45	3.47	0.50	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	67.16	1.37	0.98	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	76.92	3.03	0.89	0.71	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	88.14	3.26	1.52	0.87	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	86.86	2.11	0.47	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	100.33	5.28	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	95.40	6.66	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	87.76	2.38	1.04	0.30	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	59.07	3.79	0.60	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	83.70	4.58	0.83	0.00	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	88.31	3.20	0.69	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	70.80	1.81	1.36	0.90	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	68.96	4.80	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	71.82	2.96	0.54	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	86.53	2.62	0.87	0.70	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	77.43	4.63	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	61.36	3.12	0.55	0.37	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	62.00	0.70	1.41	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	50.01	3.07	1.32	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	65.56	0.87	0.87	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	65.42	1.86	0.37	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	89.88	5.39	1.08	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	68.38	3.28	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	61.19	3.94	1.62	0.00	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	70.06	3.25	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	110.29	3.92	0.87	0.44	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	129.59	2.54	0.92	1.15	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	119.79	4.12	1.73	1.08	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	167.25	3.74	1.71	0.47	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	158.58	3.32	1.22	1.75	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	115.28	4.24	1.11	0.67	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	157.70	2.30	2.30	1.79	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	126.25	4.17	1.54	0.88	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	119.80	3.37	0.63	0.84	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	239.81	4.06	2.03	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	234.58	5.42	2.71	2.71	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	297.22	2.07	1.04	3.11	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	280.91	9.59	2.13	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	286.26	5.90	2.68	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	236.55	4.21	2.81	2.81	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	285.51	6.27	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	309.80	6.59	1.32	2.64	3.95
CD19+ B Cells, donor1	11544-120B5	189.86	8.22	0.82	2.47	1.64
CD19+ B Cells, donor2	11624-122B4	192.24	7.98	4.35	3.63	5.80
CD19+ B Cells, donor3	11705-123B4	211.02	8.58	3.53	7.57	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	127.28	6.46	1.21	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	108.26	4.39	2.40	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	212.86	7.03	4.02	4.02	7.03
CD34+ Progenitors, donor2	11625-122B5	199.44	8.99	2.25	5.62	5.62
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	219.82	12.02	6.01	4.13	4.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	237.66	12.85	3.61	6.09	3.61
CD4+ T Cells, donor1	11225-116C1	252.80	4.28	8.57	37.13	19.28
CD4+ T Cells, donor2	11306-117C1	229.64	8.57	9.19	33.07	17.15
CD4+ T Cells, donor3	11382-118B5	205.26	5.79	8.23	30.80	15.55
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	118.68	2.81	3.83	3.32	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	163.51	2.47	2.47	3.14	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	166.73	2.30	3.16	0.86	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	388.28	8.53	6.16	10.43	8.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	509.18	6.32	3.51	12.64	7.73
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	359.29	0.00	6.59	6.59	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	114.31	2.46	2.46	1.59	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	139.98	1.53	4.24	3.90	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	122.19	2.90	3.55	2.42	1.93
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	216.98	4.93	3.59	8.52	4.48
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	226.75	5.24	2.45	7.34	5.24
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	150.03	4.84	3.08	1.76	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	122.28	1.26	2.95	2.95	4.22
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	158.94	2.91	5.19	2.29	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	165.06	0.67	4.34	3.68	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	284.72	1.36	5.17	15.77	12.51
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	313.53	3.22	3.22	14.47	9.65
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	279.74	1.79	12.55	19.73	8.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	143.89	1.85	2.78	3.52	2.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	113.07	1.95	1.73	2.60	2.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	110.33	2.52	2.52	2.73	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	246.23	3.03	2.02	15.17	9.10
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	249.99	3.90	6.93	7.37	5.63
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	185.66	6.54	4.36	6.97	9.15
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	315.23	5.94	5.44	5.94	6.43
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	319.42	11.08	8.31	10.16	6.46
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	336.39	2.79	8.37	9.77	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	234.28	4.98	3.32	4.15	5.82
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	237.54	2.45	2.70	5.40	3.44
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	318.78	4.62	9.24	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	246.03	2.86	6.80	5.73	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	340.71	2.77	5.54	5.54	4.15
CD8+ T Cells, donor1	11226-116C2	201.68	12.11	9.82	18.99	7.53
CD8+ T Cells, donor2	11307-117C2	180.96	8.26	6.38	19.52	13.52
CD8+ T Cells, donor3	11383-118B6	223.20	5.55	5.55	21.21	21.97
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	140.85	26.15	5.05	1.38	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	129.17	21.81	3.59	0.24	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	143.36	15.05	1.92	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	135.70	23.72	8.41	1.50	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	147.59	23.04	5.28	1.44	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	131.20	26.15	3.41	1.82	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	133.63	19.99	4.56	1.09	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	137.66	25.53	4.21	0.79	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	120.31	22.04	3.75	0.23	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	148.83	25.66	4.23	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	141.19	23.24	2.91	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	138.81	25.84	2.66	0.27	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	117.75	26.27	3.50	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	147.56	30.51	3.64	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	132.02	29.83	2.98	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	145.86	24.13	3.24	1.08	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	148.75	25.89	3.74	1.73	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	139.30	21.68	4.24	0.71	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	121.69	22.50	3.49	1.27	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	150.40	29.53	5.54	0.31	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	129.84	24.36	3.21	0.64	2.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	141.13	23.71	3.44	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	147.00	23.25	1.58	0.79	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	138.42	13.62	6.05	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	194.32	41.75	7.23	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	174.16	31.47	4.20	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	144.25	33.06	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	62.14	9.14	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	97.34	5.43	0.99	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	114.91	9.68	2.00	0.84	0.42
Chondrocyte - de diff, donor1	11261-116G1	99.49	8.67	1.04	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	78.89	9.60	2.13	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	126.29	8.42	1.37	0.57	0.57
Chondrocyte - re diff, donor2	11339-117F7	79.68	12.53	1.79	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	113.23	9.71	1.21	0.40	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	167.78	8.72	2.30	1.49	2.07
Ciliary Epithelial Cells, donor2	11323-117D9	145.57	9.83	2.14	2.14	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	144.78	10.35	2.30	1.24	1.77
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	107.66	5.69	3.85	3.12	1.83
Corneal Epithelial Cells, donor1	11526-119I5	37.99	2.20	0.22	0.88	0.44
Corneal Epithelial Cells, donor2	11606-120I4	51.19	2.28	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	63.14	3.58	1.02	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	76.60	2.48	0.50	0.66	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	78.85	2.52	1.89	0.95	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	120.77	3.45	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	67.28	2.16	1.19	0.32	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	215.92	10.59	8.88	12.98	11.96
Dendritic Cells - plasmacytoid, donor2	11309-117C4	306.85	5.22	11.75	23.50	13.71
Dendritic Cells - plasmacytoid, donor3	11385-118B8	223.10	9.68	4.84	15.49	15.49
Endothelial Cells - Aortic, donor0	11207-116A1	69.88	3.50	0.50	0.50	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	78.04	5.28	1.17	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	56.28	5.09	0.00	0.28	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	79.03	13.37	0.39	0.39	0.79
Endothelial Cells - Artery, donor1	11264-116G4	55.85	5.24	1.45	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	83.76	8.00	0.00	1.41	0.24
Endothelial Cells - Artery, donor3	11413-118E9	68.20	6.31	0.88	0.53	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	119.03	9.53	0.44	2.22	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	111.67	10.35	0.61	1.83	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	71.60	14.38	0.28	1.13	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	54.97	4.16	0.30	0.59	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	81.74	6.25	0.52	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	61.39	2.55	0.28	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	90.83	8.00	1.20	1.20	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	55.56	3.67	0.00	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	160.90	12.92	1.37	1.99	1.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	127.10	8.91	0.65	1.30	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	107.35	10.99	2.08	1.34	0.98
Endothelial Cells - Vein, donor1	11267-116G7	61.43	3.41	1.14	3.41	0.00
Endothelial Cells - Vein, donor2	11344-117G3	62.17	9.78	0.00	0.00	2.10
Endothelial Cells - Vein, donor3	11416-118F3	94.99	9.58	0.94	0.94	1.10
Eosinophils, donor1	12244-129H3	243.95	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	140.27	19.80	6.60	1.65	0.00
Eosinophils, donor3	12246-129H5	110.57	17.83	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	43.25	1.71	0.49	0.73	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	45.76	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	94.83	6.16	0.82	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	75.55	7.23	2.08	0.55	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	66.09	3.25	0.54	0.22	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	115.70	10.92	2.06	0.73	1.46
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	55.27	6.41	1.77	0.27	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	88.70	8.12	1.37	1.05	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	99.07	11.33	0.53	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	93.02	5.98	0.66	1.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	92.99	15.42	2.27	0.45	1.36
Fibroblast - Cardiac, donor2	11345-117G4	67.46	9.85	0.76	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	64.82	7.57	1.26	0.47	0.47
Fibroblast - Cardiac, donor4	11452-119A3	118.52	9.40	2.12	0.00	1.21
Fibroblast - Cardiac, donor5	11456-119A7	140.99	10.15	1.40	1.02	1.02
Fibroblast - Cardiac, donor6	11460-119B2	113.70	11.52	0.61	0.76	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	54.40	5.90	0.27	0.27	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	97.93	11.22	1.73	1.29	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	128.90	8.79	4.39	5.86	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	68.73	5.54	1.38	0.92	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	159.09	6.28	1.36	0.68	0.68
Fibroblast - Dermal, donor1	11269-116G9	147.68	6.34	3.99	0.47	1.88
Fibroblast - Dermal, donor2	11346-117G5	66.51	3.30	1.89	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	168.64	9.91	3.38	1.57	0.85
Fibroblast - Dermal, donor4	11450-119A1	145.38	7.01	1.47	1.24	0.79
Fibroblast - Dermal, donor5	11454-119A5	143.05	9.42	1.05	0.17	0.87
Fibroblast - Dermal, donor6	11458-119A9	149.75	9.91	1.79	2.11	0.49
Fibroblast - Gingival, donor1	11237-116D4	135.14	6.87	2.71	0.62	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	101.13	5.76	2.88	1.31	1.31
Fibroblast - Gingival, donor2	11318-117D4	135.87	5.80	2.50	1.71	0.40
Fibroblast - Gingival, donor3	11394-118C8	132.85	3.96	1.64	0.77	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	78.96	2.08	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	86.52	6.17	1.94	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	92.76	5.61	1.87	0.78	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	100.74	5.41	1.62	0.14	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	50.81	0.71	5.29	1.06	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	104.13	7.02	1.75	1.02	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	90.13	6.00	1.36	0.27	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	120.55	8.67	2.52	0.44	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	110.20	6.16	2.49	0.59	0.44
Fibroblast - Lung, donor1	11270-116H1	66.61	8.16	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	104.45	7.46	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	101.09	3.17	2.53	0.63	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	37.49	6.66	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	53.15	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	26.31	1.40	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	59.27	8.93	1.22	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	83.39	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	151.49	5.24	0.97	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	134.85	6.52	2.43	0.61	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	98.53	5.81	2.75	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	68.69	6.11	1.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	118.26	5.13	2.97	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	97.30	5.57	1.51	0.58	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	130.32	13.60	2.43	0.66	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	51.81	3.86	0.61	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	44.10	6.01	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	116.63	3.56	1.19	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	81.36	5.95	0.99	0.60	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	85.79	8.17	0.89	0.53	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	105.64	11.23	1.38	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	86.95	6.92	2.11	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	98.45	7.02	1.30	0.32	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	49.60	2.78	0.25	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	82.86	4.59	0.82	0.98	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	108.67	7.02	3.21	0.80	0.40
Fibroblast - skin normal, donor2	11561-120D4	95.14	6.63	0.60	0.40	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	58.03	4.23	2.12	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	123.94	8.20	1.82	0.58	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	115.39	8.89	0.51	0.51	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	70.28	5.25	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	98.53	7.88	0.85	0.85	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	77.09	6.07	1.18	0.84	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	88.76	5.18	0.31	0.63	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	376.72	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	195.22	19.17	3.49	0.87	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	89.97	7.45	2.77	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	86.92	7.03	0.52	1.30	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	91.47	4.85	6.13	1.02	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	336.84	23.73	7.66	3.06	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	302.45	24.88	6.38	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	372.84	25.67	9.98	0.57	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	311.05	15.44	4.96	1.10	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	200.47	12.33	6.16	0.91	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	300.76	19.22	11.29	1.59	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	266.71	13.48	4.23	0.79	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	216.56	11.74	4.57	1.30	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	322.38	22.11	12.38	0.88	4.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	271.34	9.47	5.37	0.99	2.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	179.91	10.59	2.83	0.49	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	179.71	15.58	8.06	1.61	3.76
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	161.06	11.27	3.35	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	194.90	10.80	2.63	0.69	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	151.87	12.40	4.88	2.03	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	140.56	10.95	2.05	0.46	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	162.81	8.97	1.74	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	172.24	8.52	3.28	0.44	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	138.58	12.41	1.77	0.59	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	168.18	9.70	1.75	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	136.96	8.04	2.01	1.79	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	146.59	13.51	3.02	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	132.66	11.37	2.71	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	148.61	14.63	3.55	0.71	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	178.87	9.47	2.91	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	143.96	11.95	3.24	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	174.72	11.62	1.22	0.44	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	170.30	11.98	2.91	1.33	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	143.74	15.72	2.45	0.61	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	178.45	11.14	2.48	1.03	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	197.96	9.34	2.19	0.58	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	144.92	9.84	2.17	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	167.09	10.58	0.44	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	223.48	10.82	1.97	0.25	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	107.47	10.21	2.59	0.49	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	205.58	9.62	2.89	0.96	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	161.18	8.43	1.90	0.47	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	150.27	13.60	2.85	0.95	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	121.03	7.30	3.04	0.91	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	137.26	10.45	1.78	0.31	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	183.33	9.00	2.85	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	142.52	7.57	1.96	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	100.64	8.52	1.94	0.28	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	93.32	10.43	2.14	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	99.45	11.63	3.06	0.61	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	107.39	9.33	0.91	0.65	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	139.60	8.67	1.90	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	109.50	9.40	1.29	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	96.72	5.04	0.66	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	104.13	7.93	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	86.80	6.07	1.58	1.06	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	94.83	4.84	2.42	0.61	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	110.31	6.86	2.29	0.76	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	261.17	18.31	3.78	0.80	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	228.34	12.02	2.47	0.92	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	272.71	17.39	6.34	1.02	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	192.76	16.90	7.51	0.31	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	207.68	16.95	9.04	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	281.80	26.75	9.69	1.84	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	153.44	27.22	12.37	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	172.90	20.89	9.67	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	227.83	16.04	6.42	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	177.36	17.39	10.43	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	187.80	18.88	10.09	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	189.02	22.24	8.24	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	176.61	10.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	176.74	13.42	5.03	0.84	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	179.11	12.42	9.81	0.33	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	177.83	14.26	5.03	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	202.61	14.00	7.32	0.32	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	172.21	15.62	5.43	0.34	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	208.81	18.79	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	280.62	15.46	10.31	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	193.57	10.95	2.66	0.30	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	196.52	5.08	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	169.00	18.64	4.56	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	145.67	13.35	4.37	0.23	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	136.98	26.34	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	189.90	12.69	4.61	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	169.83	12.71	4.24	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	247.47	14.71	6.02	2.68	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	256.59	11.56	3.08	0.77	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	226.97	25.68	5.48	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	270.84	12.42	4.97	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	337.37	12.27	4.25	1.42	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	283.64	11.47	5.43	1.21	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	231.45	20.86	7.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	270.81	15.16	4.79	0.40	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	323.64	10.85	7.40	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	442.67	17.71	4.72	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	351.82	16.92	3.50	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	373.05	15.36	3.95	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	282.28	22.89	2.54	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	176.09	14.33	4.78	0.60	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	158.68	17.47	1.94	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	61.63	7.99	1.14	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	42.00	3.74	0.00	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	61.84	3.37	0.00	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	95.15	7.61	1.27	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	109.87	5.01	0.84	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	174.30	16.48	8.12	1.39	1.51
Hep-2 cells mock treated, biol_rep2	11899-125E9	174.88	19.58	8.27	1.86	1.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	163.57	17.06	8.65	1.59	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	181.89	16.40	7.76	1.86	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	165.48	17.19	8.81	1.07	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	162.32	15.29	8.61	1.29	2.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	193.03	14.45	9.34	1.12	1.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	162.63	19.73	6.86	1.20	2.57
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	146.73	13.14	10.25	1.60	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	54.28	3.92	0.00	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	42.41	3.46	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	103.11	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	52.20	4.94	0.71	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.96	2.18	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	105.60	12.94	1.40	0.87	0.35
Hepatocyte, donor1	11523-119I2	71.43	9.68	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	117.43	9.70	3.23	1.08	1.08
Hepatocyte, donor3	11684-122I1	70.56	5.52	3.68	0.61	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	88.77	4.57	6.53	7.83	15.01
Intestinal epithelial cells (polarized), donor1	11246-116E4	187.72	14.16	5.24	1.05	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	122.53	7.82	2.61	1.23	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	178.30	31.84	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	160.21	26.70	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	189.58	81.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	167.51	19.38	6.92	2.77	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	127.64	22.52	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	201.76	23.74	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	156.34	17.94	7.69	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	155.41	22.85	0.00	4.57	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	227.41	19.49	11.37	1.62	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	115.04	11.67	11.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	127.07	10.89	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	255.43	19.85	11.91	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	135.25	12.20	8.87	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	251.44	31.43	20.95	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	223.60	15.12	8.19	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	160.85	13.92	4.64	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	321.96	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	208.67	18.09	10.34	1.94	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	180.31	28.98	3.22	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	346.50	0.00	35.84	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	264.02	18.74	10.59	0.00	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	152.81	14.27	7.56	0.84	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	258.70	43.12	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	262.00	20.09	12.86	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	174.50	14.77	5.54	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	377.02	30.16	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	172.29	14.16	6.61	0.00	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	126.98	10.88	8.16	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	206.39	73.71	29.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	271.18	20.45	7.53	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	175.32	13.98	7.62	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	262.89	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	226.38	15.30	3.83	2.55	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	176.80	21.87	3.65	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	316.09	47.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	211.36	16.42	7.14	2.86	5.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	182.51	23.23	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	291.88	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	187.67	13.89	4.01	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	193.16	24.58	8.78	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	229.45	40.86	0.00	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	207.23	13.21	8.34	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	146.06	4.43	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	158.86	12.97	9.73	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	206.65	6.10	2.62	0.00	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	173.23	15.75	6.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	163.77	17.42	6.97	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	189.89	19.20	3.20	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	121.92	12.47	6.93	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	173.83	28.50	5.70	5.70	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	198.81	9.20	3.68	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	148.24	18.15	12.10	3.03	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	198.68	43.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	168.12	21.15	5.29	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	66.18	5.39	2.20	1.14	0.24
Keratinocyte - epidermal, donor2	11349-117G8	42.17	3.51	1.17	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	115.29	5.11	1.99	1.42	1.04
Keratinocyte - oral, donor1	11251-116E9	254.51	9.31	2.95	1.59	1.48
Keratocytes, donor1	11527-119I6	71.17	5.50	2.75	0.00	0.00
Keratocytes, donor2	11607-120I5	44.53	2.34	0.00	2.34	0.00
Keratocytes, donor3	11688-122I5	120.73	4.94	2.17	0.20	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	74.73	6.59	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	112.19	4.31	1.08	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	158.12	7.73	2.42	0.69	0.46
Lens Epithelial Cells, donor3	11690-122I7	116.95	8.58	2.12	1.11	1.11
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	92.96	5.57	1.30	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	86.51	4.47	0.00	0.56	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	127.35	9.76	0.79	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	84.96	4.30	0.00	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	93.29	3.15	0.95	0.63	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	85.07	4.20	0.22	0.75	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	86.59	5.34	1.23	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	70.79	4.05	0.51	0.25	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	85.72	6.47	0.28	0.84	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	91.37	7.91	0.40	1.58	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	102.37	5.23	1.74	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	67.39	3.70	0.19	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	97.21	7.32	0.35	1.05	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	93.26	5.01	0.24	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	82.41	3.85	0.55	0.96	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	99.16	6.16	1.85	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	77.00	5.30	0.94	0.94	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	88.38	5.31	0.55	1.46	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	93.80	7.24	0.66	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	66.48	3.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	75.67	4.48	0.25	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	95.54	8.73	0.48	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	108.80	4.58	1.08	1.35	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	99.46	7.11	0.45	1.06	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	102.13	4.67	3.11	1.56	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	113.49	6.28	2.30	1.68	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	94.43	7.07	0.75	0.75	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	86.67	8.25	1.38	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	102.73	4.52	0.94	1.51	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	71.99	4.35	0.21	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	91.59	3.88	0.00	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	85.34	5.62	0.33	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	77.43	3.22	0.62	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	93.29	12.59	0.37	1.11	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	102.79	5.68	0.99	3.21	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	77.41	4.40	0.55	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	99.71	7.08	0.96	0.64	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	128.12	7.61	1.22	1.52	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	110.01	7.84	0.56	0.84	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	99.20	8.18	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	93.08	4.85	1.45	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	74.22	3.58	0.47	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	97.05	7.16	0.36	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	102.90	5.23	0.33	1.31	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	71.10	4.47	0.47	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	78.71	8.54	1.24	0.87	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	75.05	4.35	0.51	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	71.01	4.77	0.90	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	142.76	2.27	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	101.26	7.67	3.84	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	88.33	3.71	3.71	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	118.48	5.50	4.65	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	90.73	4.22	2.81	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	80.32	3.74	1.87	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	94.29	4.12	2.58	0.52	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	77.31	7.14	2.38	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	125.76	4.98	1.81	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	116.62	3.20	4.94	0.58	2.62
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	98.59	5.40	3.15	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	115.03	4.34	3.25	0.41	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	115.03	5.14	2.57	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	103.74	2.82	2.82	2.47	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	81.29	4.66	2.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	124.80	5.09	2.04	2.04	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	126.20	4.80	2.13	1.33	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	136.99	5.10	3.97	0.94	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	130.69	8.59	4.91	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	114.97	6.52	4.89	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	130.36	3.12	3.96	1.04	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	129.20	8.13	3.36	0.84	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	106.13	8.24	2.06	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	126.28	7.26	4.06	0.87	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	130.33	4.48	3.29	0.00	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	119.50	4.98	3.32	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	125.49	4.95	3.89	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	127.23	5.53	4.79	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	103.61	6.91	2.30	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	116.28	8.06	3.07	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	97.94	6.23	5.66	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	114.05	6.56	3.28	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	121.10	4.52	3.62	0.90	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	112.03	8.62	2.87	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	102.33	7.47	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	125.60	5.57	1.49	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	112.86	6.46	1.72	1.29	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	106.18	4.28	4.28	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	106.95	3.00	4.00	0.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	114.63	3.02	3.02	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	93.14	6.40	4.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	120.64	4.47	1.72	2.06	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	98.76	5.37	3.76	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	78.78	3.37	2.02	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	117.42	4.82	2.96	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	134.90	6.98	4.65	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	99.43	6.35	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	118.04	1.60	3.20	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	124.30	10.18	2.18	1.45	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	131.07	6.13	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	124.31	6.41	3.45	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	113.85	2.82	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	126.71	3.52	3.52	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	124.37	7.66	3.60	0.45	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	111.87	1.72	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	121.13	4.45	5.79	1.34	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	126.30	7.82	2.74	0.39	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	115.45	6.60	3.30	1.98	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	120.39	5.71	3.63	1.04	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	121.64	4.81	5.69	1.31	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	111.82	11.18	5.03	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	109.97	3.53	2.65	1.32	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	127.29	5.40	3.86	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	122.54	4.56	5.57	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	110.54	7.21	2.88	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	116.48	3.98	3.18	0.00	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	118.49	6.68	1.22	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	105.83	7.61	1.38	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	109.82	4.94	3.80	1.52	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	116.19	7.23	4.13	2.07	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	94.93	5.44	1.21	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	125.49	6.97	5.07	0.63	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	142.33	13.33	0.00	1.60	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	119.53	8.62	2.30	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	131.13	9.26	5.14	1.54	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	129.45	9.20	4.95	2.83	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	119.74	11.35	1.13	0.00	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	125.22	2.91	5.41	0.42	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	126.85	7.83	4.70	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	96.45	2.51	1.25	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	132.42	8.83	4.65	0.46	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	101.03	10.04	2.01	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	115.48	4.81	1.60	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	136.58	7.27	6.47	0.40	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	108.30	10.10	1.84	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	98.69	9.78	2.67	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	136.20	9.12	4.56	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	135.74	9.20	2.30	0.77	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	105.61	3.83	1.64	0.00	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	93.54	12.92	6.68	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	124.00	9.36	4.42	0.78	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	114.05	7.29	2.65	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	126.80	4.16	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	73.39	2.73	0.23	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	62.58	2.39	1.10	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	70.52	2.75	0.92	0.79	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	101.43	14.87	4.25	1.59	0.53
Mallassez-derived cells, donor2	11929-125I3	64.33	10.93	1.90	0.32	0.48
Mallassez-derived cells, donor3	11930-125I4	82.42	8.62	2.22	0.69	0.56
Mammary Epithelial Cell, donor1	11273-116H4	143.69	7.47	3.29	1.40	1.00
Mammary Epithelial Cell, donor2	11350-117G9	105.69	8.11	2.61	0.87	2.03
Mammary Epithelial Cell, donor3	11422-118F9	52.38	2.99	1.75	0.75	1.00
Mast cell - stimulated, donor1	11487-119E2	132.88	17.63	3.39	1.36	2.71
Mast cell, donor1	11563-120D6	119.93	4.65	1.41	1.41	0.32
Mast cell, donor2	11565-120D8	202.67	9.21	0.30	2.08	2.67
Mast cell, donor3	11566-120D9	217.25	6.30	1.80	1.80	1.13
Mast cell, donor4	11567-120E1	204.95	6.91	1.60	1.42	1.95
Mast cell, expanded and stimulated, donor5	11940-126A5	107.12	4.10	1.00	0.55	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	120.82	7.59	3.50	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	94.65	4.02	0.80	0.69	0.69
Mast cell, expanded, donor8	11941-126A6	122.85	5.52	0.50	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	112.83	10.94	0.60	1.59	0.70
Melanocyte - dark, donor2	11582-120F7	120.44	7.61	0.69	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	126.84	9.49	1.88	0.29	0.43
Melanocyte - light, donor1	11274-116H5	60.41	6.82	0.94	0.24	0.47
Melanocyte - light, donor2	11351-117H1	29.35	2.05	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	45.10	4.34	3.47	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	116.83	10.62	1.77	0.73	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	157.33	15.87	1.34	2.15	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	106.07	12.59	3.21	0.27	1.07
Meningeal Cells, donor1	11493-119E8	64.26	5.33	0.50	0.99	0.50
Meningeal Cells, donor2	11573-120E7	75.71	10.12	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	142.14	8.39	2.69	1.63	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	168.53	7.13	1.43	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	122.37	8.45	2.31	0.60	1.41
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	106.92	9.33	5.02	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	85.34	5.93	1.48	1.06	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	90.98	5.03	2.01	2.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	69.44	5.93	0.44	0.88	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	60.64	8.04	0.00	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	61.38	5.93	0.41	0.41	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	143.49	8.31	1.11	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	33.83	3.72	0.37	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	171.44	10.26	1.97	0.39	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	53.71	2.67	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	39.70	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	80.69	1.28	1.28	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	160.21	9.92	3.90	1.42	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	174.19	8.76	1.88	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	161.83	16.69	2.18	0.73	2.90
Mesothelial Cells, donor1	11247-116E5	84.06	9.55	1.86	0.80	0.80
Mesothelial Cells, donor2	12156-128G5	89.08	5.00	3.50	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	66.84	5.56	1.52	0.87	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	44.56	1.35	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	76.84	3.20	2.46	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	73.91	3.24	1.47	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	72.22	2.17	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	61.19	1.45	2.07	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	73.08	3.50	1.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	63.31	2.79	0.47	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	62.79	1.83	0.81	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	59.79	3.17	1.58	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	46.90	3.54	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	77.51	0.38	2.28	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	39.48	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	64.73	1.27	0.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	46.04	0.92	0.92	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	51.56	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	60.72	1.51	0.25	0.50	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	55.85	3.09	0.24	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	38.15	2.21	1.66	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	52.27	2.30	0.69	0.69	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	63.52	1.05	1.47	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	44.84	1.83	1.83	1.02	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	43.98	1.29	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	50.90	1.33	1.11	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	34.82	1.75	0.44	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	43.60	0.51	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	38.32	2.72	1.36	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	55.88	2.65	0.88	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	28.35	1.09	2.18	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	41.33	4.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	68.04	2.00	0.80	0.80	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	31.54	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	49.56	3.50	3.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	215.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	70.94	3.94	1.31	0.44	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	39.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.85	1.28	1.28	0.64	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	62.72	3.97	1.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	38.97	5.57	1.39	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	4.42	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	49.91	4.79	1.37	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	39.82	3.94	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	29.83	2.13	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	63.12	3.37	1.68	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	64.84	2.49	2.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	36.13	2.91	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	47.96	3.32	2.11	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	66.78	4.59	2.09	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	46.18	2.77	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	73.99	5.69	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	47.53	3.32	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	57.27	5.44	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	48.90	3.43	2.57	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	33.67	1.27	1.27	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	48.57	4.54	0.80	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	66.75	3.59	2.10	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	37.86	1.27	0.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	59.56	3.50	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	70.10	5.09	1.55	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	35.27	1.14	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	51.71	5.68	1.14	0.00	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	69.56	5.90	1.23	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	30.63	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	46.46	4.70	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	54.49	3.17	1.44	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	56.46	2.89	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	43.48	2.08	0.60	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	82.87	11.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	99.81	7.13	1.78	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	75.90	2.96	1.31	1.31	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	87.31	3.16	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	117.43	3.16	1.78	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	126.66	3.73	1.86	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	88.25	3.00	1.88	0.38	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	64.45	1.86	1.33	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	65.37	2.60	0.90	0.11	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	67.78	1.47	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	72.19	4.76	1.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	60.67	3.11	0.00	1.56	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	68.94	3.74	0.00	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	81.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	75.75	3.03	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	53.13	1.69	1.26	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	49.03	4.09	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	85.83	3.81	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	102.04	5.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	55.89	4.53	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	102.78	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	81.56	6.52	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	77.77	10.34	2.15	0.65	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	95.12	7.84	3.14	0.52	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	90.11	12.01	2.67	2.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	105.18	8.76	3.34	1.67	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	101.16	10.84	2.66	1.71	2.47
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	124.48	22.34	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	98.59	5.44	0.68	4.08	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	102.91	3.68	3.68	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	136.44	7.95	2.51	0.84	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	143.88	11.62	5.81	1.16	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	108.63	7.30	4.05	1.62	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	91.66	6.31	1.47	2.31	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	144.75	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	124.59	10.42	1.49	0.99	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	127.21	7.31	2.71	0.00	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	117.19	9.52	2.95	1.13	2.04
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	139.95	9.14	3.10	1.31	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	98.05	8.93	1.64	1.09	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	135.26	11.67	4.24	1.06	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	124.26	8.40	3.00	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	98.45	7.88	2.95	0.98	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	121.48	9.27	2.60	0.33	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	92.78	9.35	2.82	0.71	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	142.76	13.36	3.52	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	154.00	11.49	5.52	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	176.10	16.71	2.89	1.93	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	99.67	8.97	2.07	0.34	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	85.97	10.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	104.04	7.57	2.45	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	135.06	13.97	4.23	0.85	4.23
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	138.38	7.83	3.32	1.90	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	173.42	15.02	4.29	1.72	2.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	171.53	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	138.95	11.66	3.33	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	84.31	8.12	2.71	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	111.10	12.70	6.35	3.17	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	117.01	5.57	0.93	0.93	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	153.62	9.08	6.43	0.00	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	96.79	7.17	3.91	2.28	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	112.87	7.84	0.87	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	92.72	6.78	1.81	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	101.42	6.17	6.17	0.00	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	140.95	11.97	2.66	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	139.39	13.89	3.97	1.98	2.48
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	97.24	8.42	3.45	1.15	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	145.17	10.89	4.23	1.51	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	73.60	7.07	2.21	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	138.24	11.52	7.45	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	86.86	10.22	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	158.52	18.90	3.66	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	102.60	5.35	3.78	0.94	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	125.90	7.57	3.03	3.03	2.12
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	121.04	7.91	1.58	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	69.15	2.27	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	151.74	15.17	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	98.51	10.93	3.73	1.99	0.87
Myoblast, donor2	11322-117D8	111.05	9.21	2.11	0.96	0.77
Myoblast, donor3	11398-118D3	104.93	7.06	2.35	0.84	1.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	141.85	11.38	2.19	1.17	0.88
Natural Killer Cells, donor1	11230-116C6	151.91	13.84	3.08	11.38	8.92
Natural Killer Cells, donor2	11311-117C6	165.55	6.33	4.22	12.06	10.86
Natural Killer Cells, donor3	11387-118C1	147.98	7.91	4.05	13.62	9.75
Neural stem cells, donor1	11275-116H6	161.51	18.87	5.44	2.18	1.81
Neural stem cells, donor2	11352-117H2	161.75	15.41	1.93	1.93	0.00
Neurons, donor1	11494-119E9	144.51	21.62	1.14	1.14	6.83
Neurons, donor2	11574-120E8	169.97	12.77	5.50	3.74	3.74
Neurons, donor3	11655-122E8	150.46	23.84	5.76	4.93	5.76
Neutrophils, donor1	11233-116C9	50.11	7.42	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	37.69	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	52.53	7.33	0.61	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	147.71	6.41	2.26	0.71	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	131.87	2.93	0.33	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	153.62	8.82	0.60	0.80	0.60
Olfactory epithelial cells, donor1	11933-125I7	136.96	6.88	1.79	0.69	0.14
Olfactory epithelial cells, donor2	11934-125I8	127.09	8.40	2.32	1.59	1.59
Olfactory epithelial cells, donor3	11935-125I9	123.49	6.24	2.72	0.91	0.79
Olfactory epithelial cells, donor4	11936-126A1	140.45	8.08	1.85	0.97	0.88
Oligodendrocyte - precursors, donor1	11496-119F2	110.13	8.43	3.61	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	72.53	5.10	0.64	0.21	1.49
Osteoblast - differentiated, donor2	11353-117H3	83.45	3.43	4.57	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	125.38	1.86	3.10	1.24	0.62
Osteoblast, donor1	11277-116H8	49.84	5.28	0.59	0.78	0.59
Osteoblast, donor2	11354-117H4	100.43	14.05	2.11	0.70	1.40
Osteoblast, donor3	11426-118G4	110.55	9.95	3.73	1.07	1.24
Pancreatic stromal cells, donor1	11249-116E7	103.02	4.46	2.02	0.84	0.34
Pericytes, donor1	11491-119E6	27.04	1.34	0.67	0.00	0.45
Pericytes, donor2	11571-120E5	41.42	4.75	0.23	0.45	0.91
Pericytes, donor3	11652-122E5	77.31	4.48	1.63	0.81	0.81
Perineurial Cells, donor1	11499-119F5	149.53	9.27	2.37	0.90	1.13
Perineurial Cells, donor2	11579-120F4	129.46	6.44	0.92	1.47	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	147.26	4.78	1.59	9.24	6.06
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	130.76	3.92	2.69	8.08	5.63
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	123.07	3.62	3.36	6.73	5.82
Placental Epithelial Cells, donor1	11278-116H9	56.68	3.83	1.91	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	51.01	2.22	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	50.46	1.96	0.98	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	70.25	7.91	1.90	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	92.67	6.38	0.75	1.50	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	50.12	4.70	1.04	0.65	1.17
Preadipocyte - breast, donor2	11328-117E5	93.66	9.01	1.13	2.03	1.13
Preadipocyte - omental, donor1	11468-119C1	95.05	10.34	2.88	1.92	1.17
Preadipocyte - omental, donor2	11329-117E6	91.66	13.09	3.06	1.31	1.31
Preadipocyte - omental, donor3	11403-118D8	92.25	10.74	5.44	1.43	0.86
Preadipocyte - perirenal, donor1	11469-119C2	68.90	8.86	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	36.24	6.45	1.54	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	137.23	12.57	3.54	2.12	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	126.52	10.73	4.60	1.87	2.04
Preadipocyte - visceral, donor1	11280-116I2	133.48	10.43	2.98	1.58	1.40
Preadipocyte - visceral, donor2	11357-117H7	116.89	10.12	2.30	0.92	1.84
Preadipocyte - visceral, donor3	11429-118G7	97.49	9.72	1.25	0.63	1.99
Prostate Epithelial Cells (polarized), donor1	11253-116F2	166.39	15.39	9.20	1.36	0.75
Prostate Epithelial Cells, donor2	11331-117E8	73.94	7.72	3.93	1.49	0.68
Prostate Epithelial Cells, donor3	11404-118D9	117.82	4.72	3.80	1.96	0.86
Prostate Stromal Cells, donor1	11254-116F3	109.57	9.00	2.85	0.68	0.34
Prostate Stromal Cells, donor2	11332-117E9	112.60	5.20	1.97	0.72	0.18
Prostate Stromal Cells, donor3	11405-118E1	106.15	6.99	2.82	0.73	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	67.52	5.11	0.73	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	141.33	5.75	1.39	1.04	0.69
Renal Epithelial Cells, donor1	11517-119H5	36.52	2.54	0.00	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	54.77	5.69	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	156.47	5.19	1.80	0.64	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	44.26	3.40	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	72.91	7.68	0.94	0.40	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	106.57	9.32	2.22	0.67	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	24.62	3.33	0.00	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	47.32	3.74	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	70.22	6.27	1.25	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	34.68	2.50	0.83	0.00	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	91.26	3.22	2.42	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	84.34	2.11	1.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	76.56	3.28	2.12	0.58	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	188.76	8.82	4.41	1.81	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	101.19	5.40	1.42	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	45.28	4.12	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	167.61	11.79	4.01	0.50	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	107.18	6.41	1.07	0.27	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	50.92	1.79	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	29.72	3.30	1.10	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	37.12	2.90	1.16	2.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	30.56	4.68	0.78	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.59	2.88	0.50	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	46.73	3.90	1.56	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	42.30	2.85	0.99	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	35.55	1.63	1.05	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	36.52	1.85	1.16	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.77	2.60	0.41	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.72	1.36	0.91	0.45	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.78	2.69	1.61	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	25.25	2.01	0.43	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.15	2.36	1.07	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	33.41	2.66	1.33	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	17.97	2.29	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	32.05	3.54	1.21	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	42.47	3.19	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.83	2.65	0.80	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	34.56	2.53	1.56	0.10	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	39.34	2.67	1.53	0.38	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	26.48	1.82	0.43	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	24.67	3.08	0.84	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	34.69	2.56	1.20	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.80	2.73	0.91	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	32.62	3.19	0.74	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	39.49	1.88	1.07	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.59	2.59	0.47	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	35.71	2.18	1.39	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	32.97	3.04	1.64	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	22.81	1.66	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	34.29	3.54	0.44	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	36.76	3.34	1.46	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	23.55	2.56	0.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	30.31	3.41	1.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	42.80	2.12	1.54	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	22.87	3.09	0.17	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	33.47	3.02	1.10	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	34.48	2.96	1.48	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.60	2.05	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	33.29	1.92	1.18	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.45	1.87	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	31.25	2.90	0.55	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	33.57	2.38	1.90	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	36.28	2.22	1.41	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	32.77	1.88	0.38	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	38.43	4.19	1.75	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	30.52	3.93	0.30	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	29.86	2.33	0.61	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	63.02	5.39	1.75	0.29	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	34.07	5.48	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	27.43	2.11	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	47.27	3.17	0.68	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	47.63	2.40	1.80	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	33.65	4.01	0.47	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	50.59	4.27	1.92	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	37.86	3.61	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	59.43	3.20	0.56	0.19	0.19
Schwann Cells, donor2	11578-120F3	105.47	6.80	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	105.82	5.92	1.97	0.22	1.97
Sebocyte, donor1	11220-116B5	55.32	8.22	3.29	0.55	1.10
Sebocyte, donor2	11301-117B5	65.72	3.22	4.60	0.46	1.84
Sebocyte, donor3	11378-118B1	72.14	5.77	1.03	0.62	0.62
Sertoli Cells, donor1	11255-116F4	119.28	9.94	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	138.39	11.30	2.82	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	123.61	7.13	2.02	1.06	0.88
Skeletal Muscle Cells, donor2	11358-117H8	39.03	1.45	1.45	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	72.74	2.51	2.51	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	163.38	14.45	2.67	0.63	1.41
Skeletal Muscle Cells, donor5	11455-119A6	148.94	8.92	1.49	1.34	1.49
Skeletal Muscle Cells, donor6	11459-119B1	171.45	11.85	2.77	0.92	2.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	231.73	5.29	2.52	1.39	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	181.93	8.85	2.43	1.00	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	157.15	10.81	2.08	1.29	1.49
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	105.90	10.11	3.12	0.84	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	57.18	2.90	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	48.16	4.27	1.38	0.14	0.41
Skin - palm, donor1	10286-104F7	142.36	2.69	8.06	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	88.37	7.64	2.31	0.58	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	76.88	21.27	7.36	1.64	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	75.82	5.84	2.08	0.52	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	121.21	9.45	2.78	0.56	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	101.13	8.16	2.81	1.27	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	108.68	10.15	4.44	0.85	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	85.82	4.50	2.40	1.20	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	59.87	4.32	0.62	0.62	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	102.94	14.23	1.78	1.33	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	104.05	4.11	1.76	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	44.86	7.51	0.66	0.66	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	44.10	4.73	1.18	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	92.71	14.68	3.09	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	118.09	8.01	2.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	67.60	6.25	2.26	0.93	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	155.82	12.63	3.99	1.99	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	116.38	20.36	3.33	0.38	1.28
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	129.26	7.81	1.30	1.30	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	107.20	9.75	2.36	2.36	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	97.23	7.55	1.85	0.85	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	40.99	3.74	0.49	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	93.16	9.13	1.52	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	69.20	4.29	1.52	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	12.24	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	87.26	6.68	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	103.53	6.49	2.21	0.74	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	112.57	7.10	1.94	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	127.42	7.14	2.62	0.84	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	43.93	4.02	1.24	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	42.04	6.47	1.08	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	86.97	8.07	0.90	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	38.92	3.07	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	172.61	4.55	1.41	0.79	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	142.31	12.38	5.84	2.72	2.92
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	109.91	20.93	2.28	1.14	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	59.17	10.26	1.21	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	173.53	16.43	6.89	1.59	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	107.99	6.79	1.20	0.40	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	115.20	6.51	2.88	0.25	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	84.47	3.04	3.04	1.01	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	103.58	10.55	1.36	0.90	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	75.77	3.75	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	46.52	1.29	0.00	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	97.20	6.51	1.40	0.93	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	95.42	10.10	2.52	2.02	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	90.57	14.73	2.19	0.31	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	46.90	4.13	1.18	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	124.71	7.91	2.33	0.67	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	126.13	3.27	1.40	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	72.25	6.76	1.01	0.43	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	72.41	5.35	1.78	1.02	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	58.85	5.45	0.94	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	112.63	9.92	3.49	0.98	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	89.57	7.79	1.93	1.17	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.09	2.38	0.48	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	70.71	4.65	1.47	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	110.03	12.81	2.21	0.88	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	77.83	2.05	2.34	2.05	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	95.82	5.44	1.36	0.78	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	76.96	6.61	2.38	0.53	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	69.55	5.21	1.12	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	113.19	8.26	2.52	1.08	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	89.43	11.36	4.54	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	93.74	11.03	4.33	0.39	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	94.47	6.09	1.27	0.76	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	104.22	5.59	0.40	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	121.22	5.43	0.84	1.67	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	107.71	9.17	2.29	0.46	1.38
Synoviocyte, donor1	11291-117A4	100.99	10.60	2.02	1.68	0.17
Synoviocyte, donor2	11368-117I9	116.16	8.38	1.51	0.34	0.34
Synoviocyte, donor3	11440-118H9	105.45	6.26	0.89	0.22	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	49.31	4.29	1.43	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	37.66	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	41.22	3.01	1.16	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	66.88	1.94	1.86	0.72	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	53.73	5.41	1.93	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	52.68	5.73	2.29	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	110.97	4.80	1.72	0.49	0.37
Urethra, donor2	10319-105A4	127.69	8.99	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	37.72	2.66	1.86	0.27	0.53
Urothelial Cells, donor2	11600-120H7	58.48	3.20	1.20	1.20	0.40
Urothelial Cells, donor3	11681-122H7	53.86	2.06	0.92	0.46	0.69
Urothelial cells, donor0	11216-116B1	147.78	4.90	2.23	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	56.06	1.78	0.89	0.00	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	64.33	1.43	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	63.66	3.42	0.68	2.05	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	112.25	2.07	2.41	1.03	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	116.21	2.91	0.00	3.49	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	61.43	1.04	2.08	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	58.74	2.75	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	71.21	0.91	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	131.13	11.10	4.56	1.36	1.11
Wilms' tumor cell line:HFWT	10597-108E3	129.37	12.32	3.52	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	318.70	13.41	6.42	2.23	0.84
achilles tendon, donor2	10292-104G4	80.59	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	169.80	10.96	2.04	1.02	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	254.46	16.72	8.82	11.14	2.79
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	176.87	5.46	5.46	4.27	3.68
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	117.55	8.71	6.80	11.43	4.08
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	225.71	19.96	3.37	3.37	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	129.43	8.88	3.38	3.17	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	306.24	11.16	5.99	6.81	4.90
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	316.38	14.10	7.05	4.41	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	173.55	9.39	4.08	3.27	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	285.01	16.70	8.93	5.44	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	235.52	15.46	7.54	4.60	4.23
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	202.83	11.70	3.90	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	178.47	14.64	4.18	5.58	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	181.23	13.98	7.25	2.59	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	187.91	10.52	4.68	2.05	2.63
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	145.01	6.97	1.39	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	133.66	6.99	2.06	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	317.69	11.97	12.89	2.46	5.22
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	380.62	16.64	13.23	3.41	4.69
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	373.05	15.16	10.62	3.94	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	393.07	12.04	13.24	2.41	2.89
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	173.51	12.25	6.24	4.01	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	132.75	3.67	3.00	1.67	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	170.95	18.58	3.72	7.43	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	188.33	20.72	2.64	3.77	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	230.28	13.52	4.80	1.74	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	155.58	22.49	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	189.58	5.89	4.47	0.47	1.88
adipose tissue, adult, pool1	10010-101C1	96.48	4.96	0.47	0.31	0.47
adipose, donor1	10184-103D4	229.87	14.66	4.10	0.00	2.35
adipose, donor2	10185-103D5	311.44	13.38	6.49	0.81	3.65
adipose, donor3	10186-103D6	165.82	9.26	3.27	1.09	2.72
adipose, donor4	10187-103D7	168.15	7.80	6.93	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	153.72	6.15	3.47	2.05	2.05
adrenal gland, adult, pool1	10081-102A9	130.96	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	185.97	6.40	0.80	0.27	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	175.79	12.15	5.36	4.64	1.43
amniotic membrane cells, donor1	12235-129G3	176.90	4.41	2.55	0.93	0.93
amniotic membrane cells, donor2	12236-129G4	119.35	3.38	1.69	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	185.30	3.24	3.24	0.59	0.29
amygdala - adult, donor10196	10167-103B5	118.58	18.97	13.04	20.16	33.20
amygdala, adult, donor10252	10151-102I7	119.84	11.35	5.88	12.98	17.24
amygdala, newborn, donor10223	10360-105E9	110.06	11.30	5.81	11.94	22.27
anaplastic carcinoma cell line:8305C	10428-106D5	173.68	6.88	2.04	0.76	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	356.53	23.61	7.72	3.09	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	199.09	8.02	6.68	1.67	1.00
aorta, adult, pool1	10052-101G7	142.39	5.49	0.98	1.57	0.78
appendix, adult	10189-103D9	86.94	2.33	3.10	1.94	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	281.34	14.45	6.53	1.03	2.06
artery, adult	10190-103E1	134.51	5.43	2.72	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	258.73	23.76	4.93	0.72	1.16
b cell line:RPMI1788	10427-106D4	219.78	5.06	1.78	0.74	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	84.07	8.32	2.50	0.55	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	164.82	8.73	3.47	1.19	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	231.32	5.86	4.52	0.67	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	332.75	11.18	7.83	1.68	0.56
bladder, adult, pool1	10011-101C2	151.01	2.72	0.87	0.65	0.65
blood, adult, pool1	10053-101G8	128.45	4.43	0.00	2.21	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	47.96	2.57	1.71	0.86	0.00
bone marrow, adult	10192-103E3	83.00	7.42	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	166.06	11.28	11.28	7.18	26.65
brain, adult, pool1	10012-101C3	217.59	15.70	9.47	13.70	13.47
brain, fetal, pool1	10085-102B4	195.01	10.69	16.03	8.01	13.36
breast carcinoma cell line:MCF7	10482-107A5	159.24	4.63	3.30	0.33	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	202.21	9.74	3.50	0.62	2.00
breast, adult, donor1	10080-102A8	112.38	5.68	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	208.47	17.28	8.26	2.92	1.91
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	191.72	9.59	4.95	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	157.93	3.22	2.99	1.15	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	183.50	11.14	9.20	1.21	0.24
carcinoid cell line:NCI-H1770	10703-109H1	295.74	17.40	8.46	1.88	1.88
carcinoid cell line:NCI-H727	10735-110B6	173.48	6.34	1.97	1.64	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	183.80	6.97	3.49	4.44	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	306.10	25.02	3.99	1.86	2.66
caudate nucleus - adult, donor10196	10177-103C6	143.92	2.30	14.97	25.33	17.27
caudate nucleus, adult, donor10252	10164-103B2	118.47	7.20	8.37	24.09	17.23
caudate nucleus, adult, donor10258	10379-105H1	219.31	17.58	10.70	37.44	46.61
caudate nucleus, newborn, donor10223	10354-105E3	117.56	14.65	3.66	12.09	17.58
cerebellum - adult, donor10196	10173-103C2	203.93	26.22	0.00	2.91	5.83
cerebellum, adult, donor10252	10166-103B4	114.87	13.02	3.63	4.70	6.41
cerebellum, adult, pool1	10083-102B2	163.50	7.93	3.10	3.79	9.66
cerebellum, newborn, donor10223	10357-105E6	122.05	10.79	0.00	3.32	1.66
cerebral meninges, adult	10188-103D8	192.13	12.86	13.87	12.10	13.62
cerebrospinal fluid, donor2	10294-104G6	111.09	3.65	3.65	0.73	5.12
cervical cancer cell line:D98-AH2	10552-107I3	462.12	23.01	9.35	2.44	1.15
cervical cancer cell line:ME-180	10553-107I4	130.09	11.93	3.48	0.33	0.50
cervix, adult, pool1	10013-101C4	137.43	6.72	1.47	1.26	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	143.94	11.70	3.34	0.28	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	133.24	2.61	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	509.66	17.52	12.18	1.74	0.99
choriocarcinoma cell line:SCH	10785-110H2	335.01	12.81	6.16	1.48	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	209.19	8.30	4.03	0.71	0.71
chorionic membrane cells, donor1	12238-129G6	150.44	5.70	4.56	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	82.43	7.76	2.39	0.40	0.50
chorionic membrane cells, donor3	12240-129G8	174.74	6.04	2.75	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	72.71	5.05	12.12	6.06	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	300.06	26.32	4.23	5.96	2.31
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	247.09	24.08	6.55	2.75	2.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	247.81	17.21	7.70	2.57	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	248.65	17.66	9.19	1.94	1.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	219.70	17.71	7.13	0.81	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	403.99	23.56	15.61	5.59	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	235.87	15.12	3.39	1.82	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	216.92	10.97	2.97	2.06	1.14
clear cell carcinoma cell line:TEN	10636-108I6	262.69	11.10	5.38	0.52	0.87
colon carcinoma cell line:CACO-2	10513-107D9	180.66	13.73	6.59	0.18	0.92
colon carcinoma cell line:COLO-320	10420-106C6	400.23	7.60	8.36	2.28	2.28
colon, adult, donor1	10082-102B1	163.03	1.19	2.38	0.00	3.57
colon, adult, pool1	10014-101C5	117.50	4.00	1.53	0.47	0.59
colon, fetal, donor1	10070-101I7	164.38	5.56	4.33	1.85	0.62
common myeloid progenitor CMP, donor1	12130-128D6	128.34	0.00	9.17	4.58	9.17
common myeloid progenitor CMP, donor2	12134-128E1	250.37	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	220.54	33.14	6.80	1.70	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	220.06	24.60	4.83	1.06	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	250.01	29.75	6.20	0.99	1.83
corpus callosum, adult, pool1	10042-101F6	165.73	10.17	3.43	2.65	3.21
cruciate ligament, donor2	10295-104G7	93.20	5.67	1.62	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	100.32	6.42	0.00	0.80	0.00
diencephalon, adult	10193-103E4	119.27	12.24	8.64	9.12	11.28
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	403.66	22.27	4.82	3.90	4.36
ductal cell carcinoma cell line:KLM-1	10438-106E6	181.56	8.46	3.33	2.05	2.05
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	172.12	7.94	6.74	1.20	1.93
ductus deferens, adult	10196-103E7	133.06	7.48	1.50	0.00	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	175.71	7.20	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	136.83	8.83	2.21	1.47	0.74
dura mater, adult, donor1	10041-101F5	106.87	6.44	1.57	1.65	1.65
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	236.95	49.74	16.21	1.11	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	288.59	19.49	10.46	1.86	1.58
embryonic pancreas cell line:1B2C6	10604-108F1	153.54	8.63	1.85	1.23	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	171.03	5.15	5.75	2.42	1.82
embryonic pancreas cell line:1C3IKEI	10606-108F3	149.74	5.25	6.79	2.47	1.23
embryonic pancreas cell line:2C6	10603-108E9	137.91	6.57	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	251.40	18.10	9.72	2.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	190.48	5.98	5.07	2.36	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	184.13	11.10	4.02	0.48	0.64
epidermoid carcinoma cell line:A431	10426-106D3	163.74	10.23	4.34	1.00	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	115.92	14.19	4.18	1.10	0.88
epididymis, adult	10197-103E8	131.03	5.44	4.19	1.47	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	163.39	7.10	4.08	2.31	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	121.90	3.93	2.75	2.36	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	151.10	12.19	6.81	0.26	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	140.64	9.35	4.92	0.39	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	136.45	14.90	7.06	0.45	1.01
esophagus, adult, pool1	10015-101C6	101.08	3.82	1.38	0.42	1.17
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	200.63	10.77	5.39	1.38	1.38
eye - muscle inferior rectus, donor1	10272-104E2	74.85	7.24	0.00	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	75.75	2.10	4.21	2.10	2.10
eye - muscle medial, donor2	10299-104H2	87.80	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	110.06	11.46	1.15	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	77.24	4.37	2.91	2.91	1.46
eye, fetal, donor1	10054-101G9	132.71	9.66	2.03	0.76	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	159.51	8.72	6.28	1.92	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	126.78	7.36	2.61	0.71	0.71
frontal lobe, adult, pool1	10040-101F4	248.07	19.42	13.23	18.39	18.58
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	133.91	9.01	4.80	0.90	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	145.20	5.12	2.83	1.10	0.55
gall bladder, adult	10198-103E9	120.47	6.04	1.45	1.69	0.48
gamma delta positive T cells, donor1	11937-126A2	153.00	2.68	1.61	2.68	2.68
gamma delta positive T cells, donor2	11938-126A3	132.59	3.73	1.49	1.87	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	201.29	17.11	6.13	1.90	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	131.91	5.42	3.09	0.58	0.97
gastric cancer cell line:AZ521	10549-107H9	191.17	15.74	6.72	3.77	2.62
gastric cancer cell line:GSS	10560-108A2	304.77	14.64	2.75	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	337.43	30.38	6.40	1.60	1.60
giant cell carcinoma cell line:LU65	10487-107B1	95.46	3.56	4.13	1.49	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	319.39	6.30	3.64	0.98	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	86.55	6.24	4.24	1.00	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	107.87	6.44	3.48	1.58	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	120.50	7.02	2.53	1.12	0.84
glioblastoma cell line:T98G	10485-107A8	160.48	9.60	3.53	1.43	0.44
glioma cell line:GI-1	10413-106B8	296.10	25.77	8.20	2.64	1.46
globus pallidus - adult, donor10196	10175-103C4	159.63	18.22	8.75	9.48	14.58
globus pallidus, adult, donor10252	10161-103A8	148.41	9.76	3.42	2.20	3.17
globus pallidus, adult, donor10258	10367-105F7	113.64	16.43	5.48	8.22	9.58
globus pallidus, newborn, donor10223	10364-105F4	123.64	8.53	2.66	7.99	7.46
granulocyte macrophage progenitor, donor1	12131-128D7	132.15	9.79	12.24	19.58	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	109.28	0.00	0.00	21.86	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	240.42	20.91	10.45	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	90.88	8.96	2.24	1.28	1.28
hIPS +CCl2, biol_rep1	14383-156B9	155.18	12.86	5.05	2.30	2.75
hIPS +CCl2, biol_rep2	14384-156C1	100.60	15.55	3.66	0.46	2.74
hIPS +CCl2, biol_rep3	14385-156C2	161.02	19.97	7.73	0.64	4.51
hIPS, biol_rep1	14380-156B6	93.42	33.06	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	148.83	21.26	8.23	0.69	0.00
hIPS, biol_rep3	14382-156B8	121.38	19.86	6.62	4.41	13.24
hairy cell leukemia cell line:Mo	10712-109I1	145.40	7.18	1.15	1.44	0.86
heart - mitral valve, adult	10205-103F7	102.84	9.57	2.99	1.49	0.90
heart - pulmonic valve, adult	10206-103F8	117.93	4.97	1.57	2.09	2.09
heart - tricuspid valve, adult	10207-103F9	64.11	15.82	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	105.50	5.51	3.06	1.43	0.41
heart, adult, diseased, donor1	10051-101G6	108.16	6.39	1.70	1.70	2.13
heart, adult, pool1	10016-101C7	121.20	2.76	2.30	2.76	2.53
heart, fetal, pool1	10046-101G1	142.83	8.83	0.72	0.92	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	111.69	6.79	1.54	1.23	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	530.37	21.41	9.51	2.38	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	190.16	25.52	13.26	1.10	1.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	187.16	31.92	12.38	1.21	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	191.80	30.01	12.43	1.11	1.41
hepatoma cell line:Li-7	10484-107A7	134.35	10.12	3.56	1.00	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	125.63	6.13	2.61	0.30	1.21
hippocampus - adult, donor10196	10169-103B7	120.18	15.14	9.46	10.41	30.28
hippocampus, adult, donor10252	10153-102I9	107.36	7.14	3.67	5.92	8.37
hippocampus, adult, donor10258	10374-105G5	169.30	21.41	6.97	5.48	23.90
hippocampus, newborn, donor10223	10363-105F3	115.97	14.45	9.52	18.33	22.91
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	340.57	26.24	10.99	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	263.70	17.87	6.87	0.79	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	288.93	16.25	8.63	2.03	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	241.90	9.02	5.64	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	247.37	9.81	2.58	0.77	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	249.02	12.53	4.56	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	203.78	10.80	2.63	0.00	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	249.47	9.69	4.95	1.29	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	190.60	12.51	5.84	1.67	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	154.15	12.79	3.32	0.95	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	180.16	12.86	2.73	0.48	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	173.04	10.77	6.73	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	266.81	13.93	7.20	1.10	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	209.29	19.65	6.88	0.98	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	308.95	16.58	9.60	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	255.44	12.03	3.63	1.15	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	204.52	12.65	3.05	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	211.90	12.99	3.50	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	309.34	12.06	4.71	2.07	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	304.66	14.55	5.00	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	310.42	16.29	3.13	3.13	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	145.83	11.76	3.92	0.49	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	138.48	8.42	1.45	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	163.81	14.95	2.39	0.90	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	245.90	18.84	7.21	1.48	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	236.79	21.40	8.56	2.28	3.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	298.48	24.09	8.17	0.41	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	148.23	9.51	2.82	0.70	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	159.95	9.82	1.58	0.63	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	170.07	6.96	1.51	0.91	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	168.06	9.31	2.59	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	181.98	9.96	5.31	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	157.77	9.24	1.80	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	122.20	12.53	1.79	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	181.73	13.63	0.00	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	148.54	14.45	2.02	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	228.71	14.49	6.52	1.45	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	237.54	18.72	4.90	0.89	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	268.29	26.83	7.32	0.00	4.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	148.22	6.42	0.92	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	458.71	35.79	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	200.55	12.24	2.98	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	176.23	8.76	3.28	1.09	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	189.27	7.60	1.81	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	163.35	8.90	2.14	1.42	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	113.37	11.93	2.39	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	156.82	14.49	4.20	0.54	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	116.11	12.12	2.96	1.35	1.35
immature langerhans cells, donor1	11904-125F5	135.84	5.33	3.39	1.45	0.73
immature langerhans cells, donor2	11905-125F6	141.00	3.17	4.75	3.17	0.00
insula, adult, pool1	10039-101F3	232.61	17.51	12.21	23.56	22.43
keratoacanthoma cell line:HKA-1	10791-110H8	162.57	11.06	5.20	0.65	0.98
kidney, adult, pool1	10017-101C8	105.53	5.01	2.60	0.70	1.10
kidney, fetal, pool1	10045-101F9	114.31	6.37	1.63	0.64	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	155.94	12.50	3.98	1.42	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	280.49	6.91	3.18	0.41	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	180.01	11.56	3.85	0.92	0.55
left atrium, adult, donor1	10079-102A7	121.50	5.99	1.09	1.63	2.18
left ventricle, adult, donor1	10078-102A6	143.10	6.07	1.01	0.51	1.01
leiomyoblastoma cell line:G-402	10721-110A1	151.85	13.95	7.39	2.19	2.19
leiomyoma cell line:10964C	10569-108B2	77.96	5.75	3.23	1.44	0.36
leiomyoma cell line:15242A	10570-108B3	92.39	8.70	2.17	0.00	0.54
leiomyoma cell line:15425	10571-108B4	76.24	8.50	2.43	0.24	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	12.70	12.70	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	40.78	5.23	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	139.90	15.11	3.07	1.53	1.18
liposarcoma cell line:KMLS-1	10782-110G8	84.67	7.03	3.44	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	78.59	8.04	2.44	0.61	1.34
liver, adult, pool1	10018-101C9	91.40	6.97	1.13	0.65	0.32
liver, fetal, pool1	10086-102B5	104.42	2.82	3.76	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	150.35	16.19	4.52	3.06	4.81
locus coeruleus, adult, donor10252	10165-103B3	125.13	11.63	3.69	3.51	3.69
locus coeruleus, adult, donor10258	10375-105G6	169.85	18.62	7.62	6.77	9.59
locus coeruleus, newborn, donor10223	10362-105F2	106.00	9.25	3.79	3.36	3.79
lung adenocarcinoma cell line:A549	10499-107C4	136.73	2.91	4.01	0.55	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	128.92	3.45	8.27	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	213.15	7.12	2.64	0.13	0.40
lung, adult, pool1	10019-101D1	108.91	2.95	0.71	0.59	0.71
lung, fetal, donor1	10068-101I5	115.88	8.56	0.57	0.86	1.14
lung, right lower lobe, adult, donor1	10075-102A3	128.30	3.21	1.83	2.29	0.92
lymph node, adult, donor1	10077-102A5	117.39	1.42	0.95	1.42	0.95
lymphangiectasia cell line:DS-1	10727-110A7	295.67	8.99	3.07	1.97	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	168.59	12.98	3.47	0.00	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	113.83	8.49	5.10	0.00	0.85
mature adipocyte, donor1	12231-129F8	165.61	7.55	1.33	0.00	2.22
mature adipocyte, donor2	12232-129F9	142.99	7.06	2.28	0.42	0.21
mature adipocyte, donor3	12233-129G1	135.36	7.35	0.95	1.42	0.95
mature adipocyte, donor4	12234-129G2	161.62	5.79	0.79	0.26	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	230.40	10.25	11.44	4.05	4.05
medial frontal gyrus - adult, donor10196	10170-103B8	231.25	28.20	14.66	14.66	25.94
medial frontal gyrus, adult, donor10252	10150-102I6	149.52	11.03	6.44	12.51	10.48
medial frontal gyrus, adult, donor10258	10368-105F8	247.80	25.73	13.98	17.79	27.32
medial frontal gyrus, newborn, donor10223	10352-105E1	151.40	14.93	8.10	7.25	14.50
medial temporal gyrus - adult, donor10196	10183-103D3	233.55	21.09	11.64	22.28	29.87
medial temporal gyrus, adult, donor10252	10156-103A3	124.79	11.88	7.22	9.76	12.10
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	152.17	38.53	3.85	9.63	42.38
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	430.61	43.06	14.35	14.35	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	165.47	12.56	8.61	14.36	21.89
medulla oblongata - adult, donor10196	10174-103C3	136.29	8.44	4.54	1.95	2.60
medulla oblongata, adult, donor10252	10155-103A2	126.32	9.29	3.25	4.02	2.94
medulla oblongata, adult, pool1	10038-101F2	145.54	13.88	5.22	3.51	3.35
medulla oblongata, newborn, donor10223	10361-105F1	91.66	11.80	1.39	1.04	1.74
medulloblastoma cell line:D283 Med	10838-111E1	558.84	17.49	7.97	2.88	0.89
medulloblastoma cell line:ONS-76	10759-110E3	206.40	18.22	6.73	2.45	2.57
melanoma cell line:COLO 679	10514-107E1	141.88	11.64	5.89	2.44	1.58
melanoma cell line:G-361	10465-106H6	98.27	10.04	3.53	1.63	0.81
meningioma cell line:HKBMM	10691-109F7	149.79	7.06	1.99	0.72	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	257.30	26.43	8.81	6.17	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	209.71	26.96	8.55	7.78	3.89
mesenchymal precursor cell - adipose, donor1	11747-123G1	139.47	11.35	2.45	0.92	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	92.71	5.45	0.36	0.36	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	64.60	7.87	1.66	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	81.48	5.20	0.84	0.70	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	89.74	4.62	0.96	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	97.17	10.41	2.08	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	109.67	8.24	0.86	0.51	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	82.58	7.94	1.27	0.46	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	87.41	10.08	1.19	0.80	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	98.04	9.05	1.22	1.22	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	84.65	8.39	1.56	0.43	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	130.42	7.90	1.32	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	95.34	6.92	1.66	0.83	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	77.50	3.84	1.40	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	96.98	5.92	0.61	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	98.85	7.19	3.59	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	81.93	5.17	0.41	0.62	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	66.35	5.02	1.60	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	128.38	10.91	1.26	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	110.73	8.82	1.05	0.90	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	97.07	8.67	0.96	0.70	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	108.61	7.36	1.47	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	82.99	4.29	1.14	0.86	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	90.52	7.16	1.68	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	91.79	6.85	1.83	1.37	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	72.90	8.19	1.02	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	91.09	6.02	1.31	0.52	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	75.48	5.85	2.16	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	77.43	7.30	0.94	0.47	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	94.43	4.06	0.00	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	83.70	2.36	1.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	63.95	4.63	0.93	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	83.06	5.19	1.44	1.44	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	86.12	6.47	1.34	0.22	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	89.17	5.29	1.44	0.48	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	70.40	8.07	2.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	80.56	4.70	1.68	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	74.51	3.28	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	86.77	9.45	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	82.03	0.00	5.47	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	77.47	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	105.88	7.79	1.30	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	107.67	5.82	2.91	5.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	107.15	6.93	2.67	1.60	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	93.23	8.18	2.45	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	102.23	8.16	1.94	1.55	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	107.04	4.20	10.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	93.39	8.94	0.99	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	119.18	9.53	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	96.65	10.08	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	103.57	4.87	2.44	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	98.17	5.70	0.63	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	127.27	9.66	0.34	0.34	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	103.16	8.60	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	123.75	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	65.43	17.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	79.86	5.70	2.04	0.81	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	93.74	7.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	84.89	5.90	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	90.39	7.48	0.94	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	89.56	8.02	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	88.70	10.64	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	128.40	7.70	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	113.59	11.70	2.75	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	123.70	12.37	2.47	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	89.72	6.73	1.12	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	125.30	9.54	1.91	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	106.79	12.90	4.03	0.81	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	109.03	4.36	2.18	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	110.23	8.87	5.07	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	145.65	12.14	1.82	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	162.68	18.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	135.91	16.47	1.65	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	99.61	10.12	0.79	0.99	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	77.88	9.73	1.62	0.65	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	82.51	16.30	1.02	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	102.13	5.42	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	83.63	2.13	2.83	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	72.75	6.49	1.16	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	94.02	12.82	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	103.88	8.12	1.95	0.31	0.21
mesothelioma cell line:Mero-25	10850-111F4	108.71	9.99	2.27	0.68	0.91
mesothelioma cell line:Mero-41	10851-111F5	126.39	9.05	3.91	1.96	0.49
mesothelioma cell line:Mero-48a	10852-111F6	96.99	7.09	3.32	0.00	0.66
mesothelioma cell line:Mero-82	10853-111F7	117.21	21.55	3.15	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	130.39	14.13	2.04	1.36	0.34
mesothelioma cell line:Mero-84	10855-111F9	92.77	10.11	2.27	1.01	1.52
mesothelioma cell line:Mero-95	10856-111G1	181.99	14.70	2.48	0.62	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	98.23	9.28	3.15	0.33	1.49
mesothelioma cell line:NCI-H226	10846-111E9	43.08	3.62	2.17	0.36	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	66.28	3.25	1.20	0.85	0.17
mesothelioma cell line:NCI-H28	10845-111E8	183.47	8.40	5.09	1.53	0.76
mesothelioma cell line:No36	10857-111G2	180.39	15.66	4.24	1.63	1.96
mesothelioma cell line:ONE58	10858-111G3	97.81	9.48	1.08	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	58.15	2.88	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	48.24	2.20	0.12	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	97.46	3.05	0.18	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	136.14	6.86	3.59	0.33	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	103.64	9.54	2.76	0.42	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	162.17	5.76	4.15	1.38	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	89.44	4.19	1.52	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	357.57	15.15	4.62	2.59	2.03
myeloma cell line:PCM6	10474-106I6	172.17	7.31	1.38	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	113.63	7.10	2.03	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	85.32	6.67	0.59	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	147.97	5.35	2.23	1.67	1.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	151.13	6.10	3.09	1.47	1.03
nasal epithelial cells, donor2	12227-129F4	121.44	6.07	2.76	0.55	2.21
neuroblastoma cell line:CHP-134	10508-107D4	690.87	33.82	20.48	6.67	3.91
neuroblastoma cell line:NB-1	10539-107G8	387.27	37.23	9.35	5.05	5.05
neuroblastoma cell line:NBsusSR	10607-108F4	232.61	17.71	9.91	5.06	4.64
neuroblastoma cell line:NH-12	10555-107I6	387.42	31.31	9.69	2.98	5.59
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	478.01	10.44	11.15	22.54	25.62
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	203.99	8.55	6.81	7.92	9.82
neuroectodermal tumor cell line:TASK1	10774-110F9	456.86	15.09	7.85	4.83	5.03
neuroepithelioma cell line:SK-N-MC	10728-110A8	230.15	6.36	12.72	12.72	9.54
neurofibroma cell line:Hs 53.T	10729-110A9	99.28	9.32	1.33	1.86	1.06
neutrophil PMN, donor1	12133-128D9	29.75	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	305.09	23.85	3.04	6.43	5.07
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	617.19	41.63	16.81	15.21	7.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	113.82	7.37	1.60	0.64	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	106.42	3.42	3.42	1.05	0.79
nucleus accumbens, adult, pool1	10037-101F1	190.76	14.34	11.90	23.06	17.25
occipital cortex - adult, donor10196	10172-103C1	193.68	6.18	24.72	10.30	28.85
occipital cortex, adult, donor10252	10163-103B1	122.91	10.20	4.29	7.25	6.17
occipital cortex, newborn, donor10223	10355-105E4	148.49	16.74	7.64	14.19	19.65
occipital lobe, adult, donor1	10076-102A4	217.79	23.88	19.68	16.79	25.98
occipital lobe, fetal, donor1	10073-102A1	248.88	21.03	14.16	5.58	12.44
occipital pole, adult, pool1	10036-101E9	148.70	13.09	4.65	11.04	12.69
olfactory region, adult	10195-103E6	148.07	14.52	7.07	8.79	15.28
optic nerve, donor1	10277-104E7	220.12	18.01	8.00	8.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	254.93	13.44	7.97	1.25	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	326.71	13.88	6.05	1.65	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	133.43	6.26	3.05	0.85	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	251.23	15.82	4.16	0.81	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	103.48	6.47	1.76	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	157.90	2.80	5.61	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	268.25	17.39	7.21	1.91	1.91
ovary, adult, pool1	10020-101D2	119.67	6.81	1.92	1.05	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	107.79	7.88	1.65	1.10	1.10
pancreas, adult, donor1	10049-101G4	251.15	10.35	2.82	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	201.82	9.50	5.87	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	99.49	10.39	3.41	1.02	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	149.36	4.47	1.66	0.66	0.17
paracentral gyrus, adult, pool1	10035-101E8	211.14	21.78	9.06	17.76	16.38
parietal cortex, adult, donor10258	10373-105G4	140.93	17.62	13.21	20.55	16.88
parietal lobe - adult, donor10196	10171-103B9	155.18	19.75	10.35	8.46	8.46
parietal lobe, adult, donor10252	10157-103A4	140.52	12.83	5.70	9.69	10.55
parietal lobe, adult, pool1	10034-101E7	191.66	16.21	8.99	18.24	15.42
parietal lobe, fetal, donor1	10072-101I9	224.03	18.43	18.43	12.61	14.55
parietal lobe, newborn, donor10223	10356-105E5	140.95	11.96	4.86	13.83	20.19
parotid gland, adult	10199-103F1	224.47	15.42	3.08	5.55	1.85
penis, adult	10200-103F2	90.77	6.45	0.54	0.54	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	263.29	11.34	14.87	32.54	23.43
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	161.87	11.80	3.50	0.44	0.44
pineal gland - adult, donor10196	10179-103C8	70.95	12.90	3.87	0.65	1.29
pineal gland, adult, donor10252	10160-103A7	156.34	9.48	5.33	3.55	3.55
pineal gland, adult, donor10258	10377-105G8	88.42	14.42	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	189.21	22.26	4.05	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	177.72	10.94	2.08	2.08	2.61
pituitary gland, adult, donor10258	10378-105G9	209.41	8.51	4.26	0.85	1.70
placenta, adult, pool1	10021-101D3	94.17	5.81	1.51	0.54	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	188.71	7.95	3.84	0.79	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	126.22	7.47	3.58	1.09	0.62
pons, adult, pool1	10033-101E6	198.47	21.43	9.47	8.52	6.63
postcentral gyrus, adult, pool1	10032-101E5	193.44	16.48	8.98	15.60	16.91
promyelocytes/myelocytes PMC, donor1	12132-128D8	89.93	2.09	4.18	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	264.39	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	187.77	23.47	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	170.86	6.26	4.52	1.31	0.87
prostate cancer cell line:PC-3	10439-106E7	116.52	9.80	4.72	1.09	0.54
prostate, adult, pool1	10022-101D4	119.89	5.08	0.45	0.36	0.63
putamen, adult, donor10196	10176-103C5	176.10	11.80	19.12	50.75	34.47
putamen, adult, donor10252	10152-102I8	152.94	5.88	13.73	7.84	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	107.10	10.93	6.56	14.21	15.30
putamen, adult, donor10258, tech_rep2	10372-105G3	196.43	10.87	12.56	30.20	30.93
putamen, newborn, donor10223	10365-105F5	105.70	10.50	5.25	6.00	6.75
rectal cancer cell line:TT1TKB	10469-106I1	313.05	6.69	5.24	1.16	0.00
rectum, fetal, donor1	10067-101I4	189.17	11.13	5.56	4.17	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	107.48	2.76	2.33	0.64	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	332.61	7.87	2.90	0.41	1.24
retina, adult, pool1	10030-101E3	127.53	8.15	2.58	0.99	1.39
retinoblastoma cell line:Y79	10475-106I7	375.15	15.85	7.27	2.86	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	128.60	10.08	5.78	1.97	1.60
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	196.00	10.40	6.19	2.25	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	110.65	4.55	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	140.65	5.66	1.94	0.81	0.65
salivary acinar cells, donor2	11772-123I8	164.40	6.88	1.79	0.41	1.10
salivary acinar cells, donor3	11773-123I9	134.40	1.99	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	145.28	8.58	1.72	0.00	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	175.20	6.83	2.61	1.69	1.10
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	182.44	6.23	2.94	1.76	0.71
seminal vesicle, adult	10201-103F3	143.91	4.76	2.12	0.00	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	136.52	13.36	4.13	0.97	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	106.69	9.56	1.51	1.76	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	79.28	6.02	2.01	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	180.66	5.78	4.97	1.21	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	101.13	6.08	2.98	0.77	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	168.25	7.23	4.64	1.03	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	109.95	7.80	2.84	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	110.70	5.28	1.56	0.72	0.72
skeletal muscle, fetal, donor1	10066-101I3	120.60	6.03	2.01	2.01	1.01
skin, adult, donor1	10074-102A2	183.20	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	141.39	17.04	6.94	3.16	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	146.75	19.34	8.00	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	122.30	17.97	3.47	1.26	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	240.74	7.71	8.10	4.05	4.63
small cell lung carcinoma cell line:LK-2	10541-107H1	429.05	32.14	7.42	2.47	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	922.96	12.06	10.29	4.18	7.08
small cell lung carcinoma cell line:WA-hT	10562-108A4	151.89	23.10	5.67	1.09	2.83
small intestine, adult, pool1	10024-101D6	118.61	3.70	1.19	0.60	0.24
small intestine, fetal, donor1	10064-101I1	154.54	7.62	3.44	1.23	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	95.40	3.08	4.62	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	128.71	4.39	1.29	0.52	0.78
somatostatinoma cell line:QGP-1	10781-110G7	124.36	5.90	2.68	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	197.06	18.58	5.28	6.65	6.19
spinal cord, adult, donor10252	10159-103A6	165.99	10.25	5.13	3.94	3.55
spinal cord, adult, donor10258	10369-105F9	108.61	15.22	2.77	0.69	3.46
spinal cord, fetal, donor1	10056-101H2	134.16	18.90	7.32	4.27	3.66
spinal cord, newborn, donor10223	10359-105E8	109.29	9.64	2.30	0.92	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	89.16	9.26	2.39	1.49	0.60
spleen, adult, pool1	10025-101D7	78.64	4.30	1.10	1.10	0.66
spleen, fetal, pool1	10044-101F8	62.77	3.65	0.72	0.64	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	122.04	6.11	1.24	0.62	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	205.07	7.97	3.80	0.57	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	138.38	12.93	3.49	1.40	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	249.41	17.59	5.86	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	134.40	9.45	4.61	1.46	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	362.60	16.10	9.32	3.39	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	91.81	10.15	1.27	0.42	0.42
stomach, fetal, donor1	10062-101H8	216.80	11.75	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	235.28	10.82	3.99	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	136.88	8.10	3.95	2.70	3.12
substantia nigra, adult, donor10258	10371-105G2	118.45	20.69	6.21	3.62	9.31
substantia nigra, newborn, donor10223	10358-105E7	113.76	12.01	2.83	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	215.51	13.76	11.23	6.88	7.11
temporal lobe, adult, pool1	10031-101E4	148.86	13.39	8.14	15.85	15.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	181.63	9.26	12.82	16.38	19.94
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	130.98	10.11	4.83	3.52	7.47
tenocyte, donor1	11763-123H8	76.45	9.08	1.05	0.70	0.70
tenocyte, donor2	11765-123I1	95.38	5.34	1.91	0.38	0.00
tenocyte, donor3	11768-123I4	74.50	7.04	0.74	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	228.94	31.44	6.46	0.51	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	314.77	27.59	12.64	0.62	2.62
teratocarcinoma cell line:PA-1	10807-111A6	269.51	12.71	2.94	0.77	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	514.64	54.46	20.06	4.06	2.92
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	483.30	35.17	9.45	3.03	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	855.16	48.64	11.78	2.94	2.73
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	277.82	22.47	5.54	1.30	1.30
testis, adult, pool1	10026-101D8	112.63	10.52	2.47	0.86	0.43
testis, adult, pool2	10096-102C6	97.43	15.79	3.61	1.35	2.26
thalamus - adult, donor10196	10168-103B6	177.74	23.18	2.21	8.83	4.42
thalamus, adult, donor10252	10154-103A1	121.74	8.60	3.75	5.47	3.59
thalamus, adult, donor10258, tech_rep1	10370-105G1	121.63	43.11	3.08	1.54	16.94
thalamus, adult, donor10258, tech_rep2	10370-105G1	119.24	13.83	4.61	8.07	10.05
thalamus, newborn, donor10223	10366-105F6	85.15	13.81	4.60	0.00	4.60
throat, adult	10209-103G2	77.90	7.74	3.25	0.50	2.00
throat, fetal, donor1	10061-101H7	138.03	6.70	3.66	0.91	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	194.16	9.74	5.96	5.76	6.56
thymus, adult, pool1	10027-101D9	78.54	2.39	2.49	3.68	3.88
thymus, fetal, pool1	10043-101F7	72.53	3.22	2.29	2.81	2.49
thyroid carcinoma cell line:KHM-5M	10776-110G2	141.47	7.71	2.53	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	233.70	9.92	6.43	1.68	2.10
thyroid, adult, pool1	10028-101E1	222.08	4.29	1.12	1.12	0.65
thyroid, fetal, donor1	10060-101H6	157.14	10.28	3.16	1.32	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	132.42	9.24	3.08	0.00	0.00
tongue, adult	10203-103F5	100.71	10.00	3.26	1.16	1.16
tongue, fetal, donor1	10059-101H5	135.17	6.70	3.15	1.97	1.97
tonsil, adult, pool1	10047-101G2	115.10	5.01	2.00	1.80	0.70
trachea, adult, pool1	10029-101E2	98.65	5.07	2.04	0.82	0.90
trachea, fetal, donor1	10058-101H4	134.26	10.39	1.92	2.69	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	134.98	7.79	2.83	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	120.47	9.52	3.34	0.71	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	265.27	9.40	3.92	2.51	0.94
tridermal teratoma cell line:HGRT	10694-109G1	125.57	9.51	3.81	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	216.54	10.67	5.16	1.61	1.27
umbilical cord, fetal, donor1	10057-101H3	118.93	6.26	4.17	4.17	0.00
uterus, adult, pool1	10100-102D1	101.87	5.46	0.34	0.68	1.02
uterus, fetal, donor1	10055-101H1	134.64	6.66	4.61	2.05	2.05
vagina, adult	10204-103F6	110.50	6.46	0.65	0.65	0.00
vein, adult	10191-103E2	113.98	4.82	1.53	1.97	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	122.84	4.81	1.34	0.27	0.53